EUCTR2017-000485-29-GB进行中（未招募）1 期
Prolonged ENoxapariN in primarY Percutaneous Coronary Intervention; a Pilot Pharmacodynamic study (PENNY PCI study) - PENNY PCI Study
Dr0 个研究点目标入组 22 人开始时间: 2017年3月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •1.Age = 18
- •2.Confirmation of the diagnosis of STEMI by the clinical team on the basis of history, ECG changes and angiographic findings
- •3.Pre-treatment with either ticagrelor or prasugrel
- •4.Intention to proceed with PPCI
- •5.Feasibility to obtain informed verbal consent pre PPCI
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 0
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •1.Active bleeding that cannot be controlled by local measures
- •2.Female patients of child bearing age who have not had a sterilisation procedure
- •3.Patients with end stage renal failure requiring renal replacement therapy
- •4.Known thrombocytopenia (Platelet count < 100,000/µL)
- •5.Known history of intracranial haemorrhage
- •6.Known current treatment with oral anticoagulants
- •7.Known history of major surgery or trauma or history of GI/GU haemorrhage within the last month
- •8.Known intracranial malignancy or aneurysm
- •9.Known allergy to enoxaparin
- •10.Inability to easily understand verbal information given in English for any reason
- •11. Inability to give informed consent due to either temporary or permanent mental incapacity
研究者
相似试验
进行中（未招募）
1 期
Prolonged ENoxapariN in primarY percutaneous coronary intervention compared WIth Standard-of-carE therapy: Feasibility study (PENNYWISE Feasibility)EUCTR2018-000774-30-GBSheffield Teaching Hospitals NHS Foundation Trust100
已完成
4 期
Prolonged Enoxaparin In Primary Percutaneous Coronary Intervention; A Pilot Pharmacodynamic StudyPrimary Percutaneous Coronary InterventionNCT03146858Sheffield Teaching Hospitals NHS Foundation Trust22
已完成
4 期
Prolonged Enoxaparin in Primary Percutaneous Coronary InterventionMyocardial InfarctionNCT03568838Sheffield Teaching Hospitals NHS Foundation Trust100
招募中
3 期
The effectiveness of enoxaparin in preventing deep vein thrombosisDeep vein thrombosis.Phlebitis and thrombophlebitis of other deep vessels of lower extremitiesI80.2IRCT20210602051484N1Zanjan University of Medical Sciences200
已完成
1 期
Comparison of two drug thinning agents (unfractionated heparin and low-molecular weight heparin) for prevention of stroke after brain aneurysm treatment utilizing coils or stentsIntracranial AneurysmACTRN12616001277437Royal Brisbane and Women's Hospital154